GlassScriptPhysician profile
Colleen Emerson
NPI 1235831736
$1,218.63
in general payments reported to CMS, 2019-2025
17 companies · $801 in 2025
The $801 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $35.00 · 2024: $382 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,132 · Education: $86.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.64 |
| Education | $86.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $358.45 | 2024-2025 | Bimzelx |
| Lilly USA, LLC | $172.93 | 2024-2025 | Taltz, Ebglyss |
| Genzyme Corporation | $110.74 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $110.55 | 2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $86.99 | 2024 | |
| Incyte Corporation | $76.29 | 2024-2025 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.32 | 2025 | Spevigo |
| Regeneron Healthcare Solutions, INC. | $44.68 | 2025 | Dupixent |
| Galderma Laboratories, L.P. | $38.87 | 2025 | Nemluvio |
| E.R. Squibb & Sons, L.L.C. | $35.00 | 2023 | Sotyktu |
| Ani Pharmaceuticals, INC. | $27.69 | 2025 | Purified Cortrophin Gel |
| Otsuka America Pharmaceutical, INC. | $22.94 | 2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $20.30 | 2024 | Hyqvia |
| Amgen INC. | $18.36 | 2024 | Otezla |
| Sun Pharmaceutical Industries INC. | $17.43 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.56 | 2025 | |
| Organon LLC | $14.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Emerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.